NCT04644081

Brief Summary

The project aims to test the feasibility, acceptability, cultural appropriateness and effectiveness of LTP+CaCBT for treating postnatal depression and to enhance the mental health and wellbeing of mothers and their children in the low-income areas of Jos Nigeria. This project also aims to provide primary healthcare workers with culturally sensitive requisite skills and support to embed the proposed intervention into routine care practice and increase access to evidence-based intervention.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2020

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 25, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

March 25, 2021

Status Verified

March 1, 2021

Enrollment Period

12 months

First QC Date

October 29, 2020

Last Update Submit

March 24, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • Change in postnatal depression is being assessed

    Primary outcome measure would be assessed using the Edinburgh Postnatal Depression Scale

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in postnatal anxiety is being assessed

    Primary outcome measure would be assessed using the Generalised Anxiety Disorder (GAD7) scale

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in health is being assessed

    Primary outcome measure would be assessed using the Patient Health Questionnaire (PHQ-9)

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in social support is being assessed

    Primary outcome measures would be assessed using the Oslo Social Support Scale

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in health-related quality of life is being assessed

    Outcome measure would be assessed using the Health-related Quality of Life scale (EuroQoL-5 Dimensions)

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in service satisfaction is being assessed

    Outcome measure would be assessed using the brief Verona Service Satisfaction Scale

    Change is being assessed at end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in child physio-emotional development is being assessed

    Outcome measure would be assessed using the Ages and Stages Social-Emotional Questionnaire

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

  • Change in parenting knowledge of child development is being assessed

    Outcome measure would be assessed using the Knowledge of Expectation and Child Development Questionnaire

    Change is being assessed from baseline, end of intervention at 6 weeks and at 12 weeks post-intervention

Study Arms (2)

LTP+CaCBT

EXPERIMENTAL

The LTP+CaCBT intervention will consist of a total of 12 (social distancing) group training sessions (60-90 minutes) and will deliver two sessions on a weekly basis for six weeks.

Behavioral: LTPBehavioral: CaCBT

Treatment as Usual (TAU)

ACTIVE COMPARATOR

TAU is the routine care currently available for the treatment of postnatal depression at the primary health care sites of intervention (e.g. antidepressants and other forms of counselling services).

Drug: TAU

Interventions

LTPBEHAVIORAL

LTP is a low-literacy, sustainable programme that will provide depressed mothers with valuable skills on parenting, improve mother-child relation and mental health self-care. This is a research-based activity that enhances postpartum mental health while simultaneously promoting attachment security through building parents' ability to monitor and be sensitive to their children's cues, and thereby, actively involves in their children's mental and physical development.

Also known as: Learning Through Play
LTP+CaCBT
CaCBTBEHAVIORAL

CaCBT adopts 'here and now' problem-solving approach, which involves collaborating with families, active listening techniques, changing negative thinking, and depressive symptoms associated with postnatal depression and other forms of parenting distress.

Also known as: Cultural adapted Cognitive and Behaviour Therapy
LTP+CaCBT
TAUDRUG

TAU is the routine care currently available for the treatment of postnatal depression at the primary health care sites of intervention (e.g. antidepressants and other forms of mental health care).

Also known as: Treatment as Usual
Treatment as Usual (TAU)

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years and above
  • A mother with a child (0-3 years)
  • Able to provide full consent for their participation
  • A resident of the trial catchment areas
  • Able to complete a baseline assessment
  • Score 10 or above on Patient Health Questionnaire (PHQ-9) and tested positive for postnatal depression on the Edinburgh Postnatal Depression Scale (EPDS).

You may not qualify if:

  • Less than 18 years
  • Medical disorder that would prevent participation in a clinical trial such as Tuberculosis or heart failure
  • Temporary residents are unlikely to be available for follow up
  • Active suicidal ideation or any other severe mental disorder
  • Non-residents of Jos and environs
  • Unable to consent
  • Patients currently undergoing severe mental health treatment
  • Unable to speak English language fluently
  • Other significant physical or learning disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Jidong DE, Ike TJ, Taru MY, Pwajok JY, Nwoga CN, Jidong JE, Francis C, Mwankon SB, Haruna K, Dagona Z, Husain N. A multi-centred pilot randomised controlled trial of learning through play plus culturally adapted cognitive behaviour therapy for treating postnatal depression in Nigerian women. Front Psychiatry. 2025 May 5;16:1552406. doi: 10.3389/fpsyt.2025.1552406. eCollection 2025.

MeSH Terms

Conditions

Depression, Postpartum

Interventions

Behavior TherapyTherapeutics

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer/Lecturer

Study Record Dates

First Submitted

October 29, 2020

First Posted

November 25, 2020

Study Start

September 1, 2021

Primary Completion

August 31, 2022

Study Completion

December 30, 2022

Last Updated

March 25, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share